22 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Is It Too Late to Buy CRISPR Therapeutics Stock? https://www.fool.com/investing/2024/03/16/is-it-too-late-to-buy-crispr-therapeutics-stock/?source=iedfolrf0000001 Mar 16, 2024 - The biotech has been making a lot of noise since late last year.
Got $100? 2 Top Cathie Wood Stocks to Buy and Hold. https://www.fool.com/investing/2024/02/04/got-100-2-top-cathie-wood-stocks-to-buy-and-hold/?source=iedfolrf0000001 Feb 04, 2024 - These stocks are steals right now.
Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update https://www.zacks.com/stock/news/2212227/biotech-stock-roundup-vrtx-crsp-gene-therapy-label-expansion-allk-falls-on-update?cid=CS-ZC-FT-analyst_blog|stock_roundup-2212227 Jan 18, 2024 - Vertex (VRTX), CRSP and Allakos are in the spotlight on regulatory and pipeline updates.
Vertex (VRTX), CRSP's Casgevy Gets FDA Nod for Thalassemia https://www.zacks.com/stock/news/2211622/vertex-vrtx-crsp-s-casgevy-gets-fda-nod-for-thalassemia?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2211622 Jan 17, 2024 - This is the second approval granted to Vertex (VRTX)/CRISPR's (CRSP) gene therapy Casgevy and comes just a month after the FDA approved the therapy for sickle cell disease.
Here's Why CRISPR Therapeutics Stock Rose 54% Last Year https://www.fool.com/investing/2024/01/15/heres-why-crispr-therapeutics-stock-rose-54-last-y/?source=iedfolrf0000001 Jan 15, 2024 - Key regulatory developments sent this biotech stock higher.
1 Cathie Wood Stock Worth Buying Hand Over Fist in 2024 https://www.fool.com/investing/2023/12/31/1-cathie-wood-stock-worth-buying-hand-over-fist-in/?source=iedfolrf0000001 Dec 31, 2023 - Ark Invest holds a hefty position in this gene-editing stock. Risk-tolerant investors may want to take a page from the fund's playbook on this name.
2 Gene-Editing Stocks That Might Be the Next CRISPR Therapeutics https://www.fool.com/investing/2023/12/31/gene-editing-stocks-that-might-be-the-next-crispr/?source=iedfolrf0000001 Dec 31, 2023 - Curing rare inherited illnesses could be a lucrative business model.
1 Green Flag and 1 Red Flag for Bluebird Bio Stock https://www.fool.com/investing/2023/12/23/1-green-flag-and-1-red-flag-for-bluebird-bio-stock/?source=iedfolrf0000001 Dec 23, 2023 - The stock has been in the news lately.
3 Money-Saving Tricks for Investing in Biotech Stocks in 2024 https://www.fool.com/investing/2023/12/22/3-money-saving-tricks-for-investing-in-biotech/?source=iedfolrf0000001 Dec 22, 2023 - Doing a little math and doing a little extra research can make a big difference.
6 Words That Explain Why CRISPR Stock Isn't Soaring Despite the Recent FDA Approval for Its Gene-Editing Therapy https://www.fool.com/investing/2023/12/21/6-words-that-explain-why-crispr-stock-isnt-soaring/?source=iedfolrf0000001 Dec 21, 2023 - Should you buy CRISPR's stock on the dip?

Pages: 123

Page 1>